Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Operating Expenses | 48,075 | 35,828 | 22,578 | 4,005 |
| Operating Income | -48,075 | -35,828 | -22,578 | -4,005 |
| Other Income | 351 | -17,377 | -1,293 | -2,827 |
| Pre-tax Income | -47,724 | -53,205 | -23,871 | -6,832 |
| Income Tax | 143 | 55 | 2 | N/A |
| Net Income Continuous | -47,867 | -53,260 | -23,873 | -6,832 |
| Net Income | $-47,867 | $-53,260 | $-23,873 | $-6,832 |
| EPS Basic Total Ops | -63.20 | -1,258.80 | -2,763.20 | -767.20 |
| EPS Basic Continuous Ops | -63.32 | -147.95 | -894.74 | -417.91 |
| EPS Diluted Total Ops | -63.20 | -1,258.80 | -2,763.20 | -767.20 |
| EPS Diluted Continuous Ops | -63.32 | -147.95 | -894.74 | -417.91 |
| EPS Diluted Before Non-Recurring Items | -63.20 | N/A | N/A | N/A |
| EBITDA(a) | $-47,878 | $-35,717 | $-22,566 | $-4,004 |